Global Retirement Partners LLC Acquires New Holdings in Cigna Group $CI

Global Retirement Partners LLC purchased a new stake in Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,490 shares of the health services provider's stock, valued at approximately $823,000.

• UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC bought a new position in Cigna Group during the first quarter valued at approximately $28,000. 1248 Management LLC purchased a new stake in Cigna Group in the first quarter worth $29,000. Solstein Capital LLC bought a new position in Cigna Group in the second quarter worth about $29,000. Activest Wealth Management boosted its position in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC purchased a new stake in shares of Cigna Group in the 2nd quarter worth about $30,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Cigna Group news, CEO David Cordani bought 4,134 shares of the firm's stock in a transaction on Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, with a total value of $999,931.92. Following the purchase, the chief executive officer directly owned 157,935 shares of the company's stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Stock Performance

• Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Shares of CI opened at $278.60 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market cap of $74.42 billion, a PE ratio of 15.21, a P/E/G ratio of 0.88 and a beta of 0.44. The stock has a fifty day moving average price of $285.25 and a 200-day moving average price of $297.60. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.

Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm's quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the business posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

• MarketBeat Week in Review – 01/06 - 01/10

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, December 4th. Cigna Group's payout ratio is presently 26.64%.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Cowen restated a "buy" rating on shares of Cigna Group in a research note on Tuesday, November 4th. Truist Financial reduced their target price on shares of Cigna Group from $375.00 to $310.00 in a report on Friday, October 31st. Robert W. Baird set a $372.00 price objective on Cigna Group in a research note on Thursday, August 14th. UBS Group set a $294.00 price target on Cigna Group in a report on Wednesday, November 12th. Finally, Zacks Research lowered Cigna Group from a "hold" rating to a "strong sell" rating in a research note on Monday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $334.05.

Read Our Latest Research Report on CI

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

• Five stocks we like better than Cigna Group
• The Most Important Warren Buffett Stock for Investors: His Own
• Keysight Technologies' Surge: The Market Wakes Up to This AI Play
• How to Profit From Value Investing
• Is American Express the Credit Stock For a K-Shaped Economy?
• Roth IRA Calculator: Calculate Your Potential Returns
• Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here